全文获取类型
收费全文 | 5253篇 |
免费 | 606篇 |
国内免费 | 2篇 |
出版年
2023年 | 28篇 |
2022年 | 63篇 |
2021年 | 95篇 |
2020年 | 45篇 |
2019年 | 51篇 |
2018年 | 65篇 |
2017年 | 65篇 |
2016年 | 127篇 |
2015年 | 223篇 |
2014年 | 231篇 |
2013年 | 274篇 |
2012年 | 378篇 |
2011年 | 313篇 |
2010年 | 231篇 |
2009年 | 192篇 |
2008年 | 299篇 |
2007年 | 253篇 |
2006年 | 259篇 |
2005年 | 250篇 |
2004年 | 277篇 |
2003年 | 225篇 |
2002年 | 215篇 |
2001年 | 122篇 |
2000年 | 103篇 |
1999年 | 95篇 |
1998年 | 50篇 |
1997年 | 46篇 |
1996年 | 29篇 |
1995年 | 41篇 |
1994年 | 34篇 |
1993年 | 39篇 |
1992年 | 52篇 |
1991年 | 52篇 |
1990年 | 68篇 |
1989年 | 59篇 |
1988年 | 59篇 |
1987年 | 53篇 |
1986年 | 63篇 |
1985年 | 49篇 |
1984年 | 37篇 |
1983年 | 37篇 |
1982年 | 32篇 |
1981年 | 32篇 |
1979年 | 44篇 |
1978年 | 28篇 |
1976年 | 24篇 |
1975年 | 24篇 |
1973年 | 26篇 |
1972年 | 24篇 |
1971年 | 24篇 |
排序方式: 共有5861条查询结果,搜索用时 15 毫秒
991.
Nick R. Leslie Helene Maccario Laura Spinelli Lindsay Davidson 《Advances in enzyme regulation》2009,49(1):190-196
Many hundreds of research papers over the last ten years have established the significance of PTEN's lipid phosphatase activity in mediating many of its effects on specific cellular processes in many different cell types, including cell growth, proliferation, survival, and migration ([Backman et al., 2002], [Iijima et al., 2002], [Leslie and Downes, 2002] and [Salmena et al., 2008]). In some cases, detailed signalling mechanisms have been identified by which these PtdInsP3-dependent effects are manifest ([Kolsch et al., 2008], [Manning and Cantley, 2007] and [Tee and Blenis, 2005]). Further, in some settings, in vivo data from, for example genetic deletion of PTEN, relates closely with independent manipulation of the PI3K/Akt signalling pathway ([Bayascas et al., 2005], [Chen et al., 2006], [Crackower et al., 2002] and [Ma et al., 2005]). Together these studies indicate that the dominant effects of PTEN function are mediated through its regulation of PtdInsP3-dependent signalling, but that its protein phosphatase activity also contributes in some settings. These conclusions are of great importance given the intense efforts underway to develop PI3K (EC 2.7.1.153) inhibitors as cancer therapeutics. The experiments reviewed here have firmly established that the protein phosphatase activity of PTEN plays a role in the regulation of cellular processes including migration. On the other hand, it has not been established beyond doubt that PTEN acts on substrates other than itself; no such substrates have been confidently identified and effector mechanisms for PTEN's protein phosphatase activity are currently unclear. The goal for future research must be firstly to understand the signalling mechanisms by which PTEN protein phosphatase activity acts: whether this is through identifying substrates, or working out how autodephosphorylation mediates its effects. Secondly, and critically, the significance of PTEN's protein phosphatase activity must be established in vivo. This can be achieved through relating the phenotypes intervening with both PTEN and with protein phosphatase effector pathways when they are identified, and through the generation of mouse models expressing substrate selective PTEN mutants. We should then be able to answer the important question of whether PTEN's protein phosphatase activity contributes to tumour suppression. 相似文献
992.
993.
994.
Gregory Q. Del Prete Beth Haggarty George J. Leslie Andrea P. O. Jordan Josephine Romano Nathaniel Wang Jianbin Wang Michael C. Holmes David C. Montefiori James A. Hoxie 《Journal of virology》2009,83(19):9911-9922
Like human immunodeficiency virus type 1 (HIV-1), most simian immunodeficiency virus (SIV) strains use CCR5 to establish infection. However, while HIV-1 can acquire the ability to use CXCR4, SIVs that utilize CXCR4 have rarely been reported. To explore possible barriers against SIV coreceptor switching, we derived an R5X4 variant, termed 239-ST1, from the R5 clone SIVmac239 by serially passaging virus in CD4+ CXCR4+ CCR5− SupT1 cells. A 239-ST1 env clone, designated 239-ST1.2-32, used CXCR4 and CCR5 in cell-cell fusion and reporter virus infection assays and conferred the ability for rapid, cytopathic infection of SupT1 cells to SIVmac239. Viral replication was inhibitable by the CXCR4-specific antagonist AMD3100, and replication was abrogated in a novel CXCR4− SupT1 line. Surprisingly, parental SIVmac239 exhibited low-level replication in SupT1 cells that was not observed in CXCR4− SupT1 cells. Only two mutations in the 239-ST1.2-32 Env, K47E in the C1 domain and L328W in the V3 loop, were required for CXCR4 use in cell-cell fusion assays, although two other V3 changes, N316K and I324M, improved CXCR4 use in infection assays. An Env cytoplasmic tail truncation, acquired during propagation of 239-ST1 in SupT1 cells, was not required. Compared with SIVmac239, 239-ST1.2-32 was more sensitive to neutralization by five of seven serum and plasma samples from SIVmac239-infected rhesus macaques and was approximately 50-fold more sensitive to soluble CD4. Thus, SIVmac239 can acquire the ability to use CXCR4 with high efficiency, but the changes required for this phenotype may be distinct from those for HIV-1 CXCR4 use. This finding, along with the increased neutralization sensitivity of this CXCR4-using SIV, suggests a mechanism that could select strongly against this phenotype in vivo.Simian immunodeficiency viruses (SIVs) share many structural and biological features with human immunodeficiency virus (HIV), including target cell entry via interactions of the viral envelope glycoprotein (Env) with CD4 and a chemokine coreceptor. For HIV, the most important coreceptors in vivo are CCR5 (2, 13, 19, 21, 22) and CXCR4 (30). HIV type 1 (HIV-1) strains that use only CCR5 (R5 viruses) predominate during the early stages of infection and are critical for transmission (84, 90), as evidenced by the finding that individuals lacking a functional CCR5 protein due to a homozygous 32-bp deletion in the CCR5 gene (ccr5-Δ32) are largely resistant to HIV-1 infection (16, 54, 82). Although R5 viruses generally persist in late-stage disease, viruses that can use CXCR4, either exclusively (X4 viruses) or in addition to CCR5 (R5X4 viruses), emerge in approximately 50% of subtype B-infected individuals (15, 43). This coreceptor switch is associated with a more rapid decline in peripheral blood CD4+ T cells and a faster progression to AIDS (15, 43, 77), although it is unclear if CXCR4-using viruses are a cause or a consequence of progressing immunodeficiency. Like HIV, the vast majority of SIVs use CCR5 to establish infection (11, 12, 45). However, although CXCR4-using SIVs have been reported (47, 52, 65, 68, 69), their occurrence is rare, especially in models of pathogenic infection, where only one CXCR4-using SIV has been identified (17, 60, 71).This paucity of CXCR4-using SIVs is surprising for several reasons. First, SIV Envs tend to be more promiscuous than HIV-1 Envs and frequently use alternative coreceptors in addition to CCR5, including GPR1, GPR15, CXCR6, and CCR8 (20, 27, 29, 80, 81, 92) but not CXCR4. Second, HIV-2, which is more closely related to SIVmac than to HIV-1 (56, 57), commonly uses CXCR4 in vitro and in vivo (3, 28, 33, 58, 59, 67). Third, rhesus CXCR4 is ∼98% identical to human CXCR4 in amino acid sequence and can function as a coreceptor for HIV-1 in vitro (12). Finally, chimeric simian-human immunodeficiency viruses (SHIVs) that contain X4 HIV Envs on an SIV core can replicate to high levels in vivo and cause disease in rhesus macaques (39, 86). Moreover, it was recently shown that coreceptor switching can occur in rhesus macaques infected with an R5 SHIV (35). Thus, there does not appear to be any block per se against the use of rhesus CXCR4 as an entry coreceptor either in vitro or in vivo, suggesting that SIV is less capable of adapting to use CXCR4 and/or that mutations required for CXCR4 utilization may lead to a virus that is less fit and/or more susceptible to immune control in this host.For HIV-1, the Env determinants for CXCR4 use have been well documented and often involve the acquisition of positively charged amino acids in the V3 loop (18, 32, 87), particularly at positions 11, 24, and 25 (6, 18, 31, 32, 38, 75). Although the SIVmac239 V3 loop is a critical determinant for Env-coreceptor interactions (44, 63, 72), attempts to create an X4 SIVmac239 by introducing positively charged residues into the V3 loop (63) or by inserting a V3 loop from X4 HIV-1 (44) have been unsuccessful. SIVmac155T3, the only CXCR4-using variant of SIVmac that has been identified to date, was isolated from a rhesus macaque with advanced disease and contains additional positively charged residues in V3, although the determinants for CXCR4 use have not been determined (60, 71).Given questions concerning the possible determinants for and/or barriers to coreceptor switching in SIV, we sought to derive a CXCR4-using variant of the well-characterized pathogenic R5 SIV clone SIVmac239. Here we show that SIVmac239 could indeed acquire CXCR4 utilization when it was adapted in vitro for high-efficiency replication in the CXCR4+ CCR5− human SupT1 cell line. An env clone from this virus could use CXCR4 in cell-cell fusion and reporter virus infection assays and conferred CXCR4 tropism to a replication-competent SIV. Although V3 mutations were important for CXCR4 use, an L328W change at the V3 crown rather than the acquisition of positively charged residues was required, as was an unusual K47E mutation in the conserved C1 domain of gp120. These changes also caused the highly neutralization-resistant SIVmac239 strain to become more neutralization sensitive to sera and plasmas from SIVmac239-infected animals, and particularly to soluble CD4. These results indicate that mutations distinct from those typically seen for HIV-1 may be required for SIVmac to gain CXCR4 utilization and suggest that these changes render this virus more susceptible to humoral immune control. Collectively, our findings indicate that there are likely to be strong viral and host selection pressures against CXCR4 use that may contribute to the paucity of X4 coreceptor switching for SIVmac in vivo. 相似文献
995.
Gail Ferstandig Arnold Paola K. Velasco Andrew K. Holmes Terri Wrin Sheila C. Geisler Pham Phung Yu Tian Dawn A. Resnick Xuejun Ma Thomas M. Mariano Christos J. Petropoulos John W. Taylor Hermann Katinger Eddy Arnold 《Journal of virology》2009,83(10):5087-5100
In efforts to develop AIDS vaccine components, we generated combinatorial libraries of recombinant human rhinoviruses that display the well-conserved ELDKWA epitope of the membrane-proximal external region of human immunodeficiency virus type 1 (HIV-1) gp41. The broadly neutralizing human monoclonal antibody 2F5 was used to select for viruses whose ELDKWA conformations resemble those of HIV. Immunization of guinea pigs with different chimeras, some boosted with ELDKWA-based peptides, elicited antibodies capable of neutralizing HIV-1 pseudoviruses of diverse subtypes and coreceptor usages. These recombinant immunogens are the first reported that elicit broad, albeit modest, neutralization of HIV-1 using an ELDKWA-based epitope and are among the few reported that elicit broad neutralization directed against any recombinant HIV epitope, providing a critical advance in developing effective AIDS vaccine components.The development of an AIDS vaccine is an ongoing and urgent challenge. One of the major hurdles is that the specific correlates of protection against human immunodeficiency virus (HIV) are still largely unknown. Nonetheless, most agree that the full complement of cellular and humoral components of the immune system will be needed to combat this virus. This is especially true given that the virus resides permanently in its host, infects the very cells needed to direct effective immune responses, and evades the immune system, either by changing in appearance or hiding in subcellular compartments.A broadly reactive neutralizing antibody response is likely to be critical as a first line of defense upon initial HIV exposure by aiding in the clearance of cell-free virions, targeting infected cells for destruction, and preventing viral spread through cell-to-cell transmission. The presence of inhibitory antibodies in highly exposed persistently seronegative individuals testifies to the importance of the humoral response (9, 37). Additionally, broadly neutralizing serum has been associated with healthier prognoses for infected individuals (27, 65) and may be vital for protecting offspring from their infected mothers (7, 79) and preventing superinfection by heterologous HIV strains (23, 84). Even if complete protection cannot be achieved by vaccine-derived antibodies, an early, well-poised and effective neutralizing antibody repertoire may be able to lower the set point of the viral load following the initial burst of viremia, an outcome that has been reported to translate into improved disease outcomes and reduced transmission of HIV (66, 74). Further benefits of neutralizing antibodies have been seen with passive immunization studies in macaques, in which administration of broadly neutralizing monoclonal antibodies (MAbs) has demonstrated that it is possible to provide protection from—and even sterilizing immunity against—HIV infection (5, 51, 66). There is also evidence that such antibodies may provide therapeutic benefits for chronically infected individuals, analogous to benefits realized with anti-HIV drug treatment regimens (87).Despite the promising potential of broadly neutralizing MAbs, designing immunogens that can elicit such cross-reactive neutralizing responses against HIV has been a surprisingly difficult task. Since the majority of the host''s B-cell response is directed against the envelope (Env) glycoproteins, gp120 and gp41, vaccine efforts have concentrated on these proteins and derivatives thereof in approaches ranging from the use of Env-based peptide cocktails to recombinant proteins and DNAs made with varied or consensus sequences and diverse, heterologous prime/protein boost regimens (reviewed in references 36, 58, and 70). These iterative studies have shown notable improvements in the potency and breadth of neutralizing responses induced. However, concerns exist regarding immunogens containing extraneous epitopes, as is the case with intact subunits of Env, and the nature of the immune responses they may elicit. A polyclonal burst of antibodies against a multitude of nonfunctional epitopes may include a predominance of antibodies that are (i) low affinity and/or nonfunctional (reviewed in reference 72); (ii) isolate specific (25); (iii) able to interfere with the neutralizing capabilities of otherwise-effective antibodies (via steric hindrance or by inducing various forms of B-cell pathology) (67); or (iv) directed against irrelevant epitopes instead of more conserved (and sometimes concealed) epitopes that might be able to elicit more potent and cross-reactive neutralizing responses (28, 71, 91).We have developed a system that can be used to present essentially any chosen epitope in a stable, well-exposed manner on the surface of the cold-causing human rhinovirus (HRV). HRV is itself a powerful immunogen and is able to elicit T-cell as well as serum and mucosal B-cell responses (reviewed by Couch [22]) and has minimal immunologic similarity to HIV (data not shown). Chimeric viruses displaying optimal epitopes should be able to serve as valuable components in an effective vaccine cocktail or as part of a heterologous prime/boost protocol. We have shown previously that HRV chimeric viruses displaying HIV-1 gp120 V3 loop sequences are able to elicit neutralizing responses against HIV-1 (75, 82, 83).In this study, we focused our attention on presenting part of the membrane-proximal external region (MPER) of the transmembrane glycoprotein gp41, a region of approximately 30 amino acids adjacent to the transmembrane domain (reviewed in references 59 and 97). The MPER plays an important role in the process of HIV fusion to the host cell membrane (60, 78). This region is also involved in binding to galactosylceramide, an important component of cell membranes, thus permitting CD4-independent transcytosis of the virus across epithelial cells at mucosal surfaces (1, 2). These functions likely explain this region''s sequence conservation and the efficacy of antibodies directed against the MPER (97), particularly given that an estimated 80% of HIV-1 infections are sexually transmitted at mucosal membranes. In fact, potent responses against the MPER are associated with stronger and broader neutralizing capabilities in infected individuals (68). A conserved, contiguous sequence of the MPER, the ELDKWA epitope (HIV-1 HxB2 gp41 residues 662 to 668), is recognized by the particularly broadly neutralizing human MAb 2F5 (11, 62, 85) and is highly resistant to escape mutation in the presence of 2F5 (49). 2F5 was also used in the MAb cocktails reported to confer passive, protective immunity in macaques (5, 51). In addition, infected individuals producing neutralizing antibodies directed against the ELDKWA epitope have been seen to exhibit better health (16, 29), including persistent seronegativity (8), and reduced transmission of HIV to offspring (89). While none of the vaccine-induced immune responses generated against this region has been effective thus far (19, 24, 26, 33, 35, 38, 40, 42, 44-48, 50, 53, 54, 56, 57, 61, 63, 69, 93, 96) (see Table S1 in the supplemental material), more appropriate presentations of MPER epitopes should produce valuable immunogens that can contribute to a successful vaccine.In this study, we have grafted the ELDKWA epitope onto a surface loop of HRV connected via linkers of variable lengths and sequences and selected for viruses well recognized and neutralized by MAb 2F5. In so doing, we have been able to create immunogens capable of eliciting antibodies whose activities mimic some of those of 2F5. The combinatorial libraries produced were designed to encode a large set of possible sequences and, hence, structures from which we could search for valuable conformations. This work illustrates that HRV chimeras have the potential to present selected HIV epitopes in a focused and immunogenic manner. 相似文献
996.
997.
Carbon Mineralization and Labile Organic Carbon Pools in the Sandy Soils of a North Florida Watershed 总被引:1,自引:0,他引:1
Mi-Youn Ahn Andrew R. Zimmerman Nick B. Comerford James O. Sickman Sabine Grunwald 《Ecosystems》2009,12(4):672-685
The large pool of actively cycling carbon (C) held in soils is susceptible to release due to changes in landuse, management,
or climate. Yet, the amount and distribution of potentially mineralizable C present in soils of various types and the method
by which this soil C fraction can best be quantified, are not well established. The distribution of total organic C (TOC),
extractable C pools (hot-water-extractable and acid-hydrolyzable), and in vitro mineralizable C in 138 surface soils across
a north Florida watershed was found to be quite heterogeneous. Thus, these C quality parameters could not statistically distinguish
the eight landuses or four major soil orders represented. Only wetland and upland forest soils, with the largest and smallest
C pool size, respectively, were consistently different from the soils of other landuse types. Variations in potential C mineralization
were best explained by TOC (62%) and hot-water-extractable C (59%), whereas acid-hydrolyzable C (32%) and clay content (35%)
were generally not adequate indicators of C bioavailability. Within certain landuse and soil orders (Alfisol, Wetland and
Rangeland, all with >3% clay content), however, C mineralization and clay content were directly linearly correlated, indicating
a possible stimulatory effect of clay on microbial processing of C. Generally, the sandy nature of these surface soils imparted
a lack of protection against C mineralization and likely resulted in the lack of landuse/soil order differences in the soil
C pools. If a single parameter is to be chosen to quantify the potential for soil C mineralization in southeastern U.S. coastal
plain soils, we recommend TOC as the most efficient soil variable to measure.
Author Contributions Conceived of or designed study: Sabine Grunwald, Nick Comerford, and James Sickman—Performed research: Mi-Youn Ahn—Analyzed
data: Mi-Youn Ahn, Andrew Zimmerman, and Nick Comerford—Contributed new methods or models: Andrew Zimmerman, Nick Comerford,
and James Sickman—Wrote the paper: Mi-Youn Ahn, Andrew Zimmerman, and Nick Comerford. 相似文献
998.
Charlotte Vandenberghe Gina Prior Nick A. Littlewood Rob Brooker Robin Pakeman 《Basic and Applied Ecology》2009,10(7):662-670
Changes in grazing management are believed to be responsible for declines in populations of birds breeding in grassland over the last decades. The relationships between grazing management regimes, vegetation structure and composition and the availability of invertebrate food resources to passerine birds remain poorly understood. In this study, we investigated the foraging site selection of meadow pipits (Anthus pratensis L.) breeding in high intensity sheep-grazed plots or low intensity mixed (i.e. sheep and cattle)-grazed plots. We sampled above-ground invertebrates, measured vegetation height and density and conducted a vegetation survey in areas where meadow pipits were observed to forage and areas that were randomly selected. Birds foraged in areas with a lower vegetation height and density and in areas containing a lower proportion of the dominant, tussock-forming grass species Molinia caerulea. They did not forage in areas with a total higher invertebrate biomass but at areas with preferred vegetation characteristics invertebrate biomass tended to be higher in foraging sites than random sites. The foraging distance of meadow pipits was higher in the intensively grazed plots. Our findings support the hypothesis that resource-independent factors such as food accessibility and forager mobility may determine patch selection and are of more importance as selection criteria than food abundance per se. Food accessibility seems to become an even more important selection criterion under high grazing intensity, where prey abundance and size decrease. In our upland grazing system, a low intensity, mixed grazing regime seems to provide a more suitable combination of sward height, plant diversity, structural heterogeneity and food supply for meadow pipit foraging activity compared to a more intensive grazing regime dominated by sheep. 相似文献
999.
1000.
Wu Yin Stefano Romeo Shurong Chang Nick V. Grishin Helen H. Hobbs Jonathan C. Cohen 《The Journal of biological chemistry》2009,284(19):13213-13222
Angiopoietin-like protein 4 (ANGPTL4) is a secreted protein that modulates
the disposition of circulating triglycerides (TG) by inhibiting lipoprotein
lipase (LPL). Here we examine the steps involved in the synthesis and
post-translational processing of ANGPTL4, and the effects of a naturally
occurring sequence variant (E40K) that is associated with lower plasma TG
levels in humans. Expression of the wild-type and mutant proteins in HEK-293A
cells indicated that ANGPTL4 formed dimers and tetramers in cells prior to
secretion and cleavage of the protein. After cleavage at a canonical
proprotein convertase cleavage site (161RRKR164), the
oligomeric structure of the N-terminal domain was retained whereas the
C-terminal fibrinogen-like domain dissociated into monomers. Inhibition of
cleavage did not interfere with oligomerization of ANGPTL4 or with its ability
to inhibit LPL, whereas mutations that prevented oligomerization severely
compromised the capacity of the protein to inhibit LPL. ANGPTL4 containing the
E40K substitution was synthesized and processed normally, but no monomers or
oligomers of the N-terminal fragments accumulated in the medium; medium from
these cells failed to inhibit LPL activity. Parallel experiments performed in
mice recapitulated these results. Our findings indicate that oligomerization,
but not cleavage, of ANGPTL4 is required for LPL inhibition, and that the E40K
substitution destabilizes the protein after secretion, preventing the
extracellular accumulation of oligomers and abolishing the ability of the
protein to inhibit LPL activity.Angiopoietin-like protein 4
(ANGPTL4)4 is a 50-kDa
protein that is synthesized and secreted from several metabolically active
tissues and has been implicated in the trafficking of circulating TG
(1,
2). Triglycerides, either
acquired from the diet or synthesized endogenously, circulate in blood as
constituents of chylomicrons and very low density lipoproteins (VLDL). As
these lipoproteins circulate in tissues they encounter lipoprotein lipase
(LPL) at the vascular endothelial surfaces. LPL hydrolyzes the TG, producing
free fatty acids that are taken up by the surrounding tissues. ANGPTL4
inhibits the activity of LPL, thereby limiting the uptake of TG-derived fatty
acids by the underlying cells
(3,
4). Overexpression of ANGPTL4
in mice causes severe hypertriglyceridemia, whereas mice lacking ANGPTL4 have
increased LPL activity and low plasma levels of TG
(5,
6). In mice, ANGPTL4 is
predominantly expressed in adipose tissue and is strongly induced by fasting
(2). Accordingly it has been
proposed that ANGPTL4 inhibits LPL activity in adipose tissue to reroute fatty
acids away from fat to muscle and other tissues when food intake is low
(3,
4).ANGPTL4 belongs to a family of seven structurally similar secreted proteins
(ANGPTL1-ANGPTL7) that contain a signal sequence followed by an
α-helical region predicted to form a coiled-coil, and a globular
fibrinogen-like domain at the C terminus
(1). Gel filtration studies of
recombinant ANGPTL4 indicate that the protein assembles into oligomers that
are stabilized by disulfide bonds
(7). Substitution of two highly
conserved cysteine residues at positions 76 and 80 in the α-helical
domain prevents oligomerization of ANGPTL4 and impairs the ability of the
recombinant protein to increase plasma TG levels when overexpressed in the
livers of rats (7).Upon secretion into the circulation, ANGPTL4 is cleaved into an N-terminal
domain and a C-terminal fibrinogen-like domain
(8). The N-terminal peptide
circulates as an oligomer, and the fibrinogen-like domain circulates as a
monomer (8). The N-terminal
helical region of ANGPTL4 is necessary and sufficient for inhibition of LPL
(9). A peptide corresponding to
amino acids 1-187 of the protein binds LPL with high affinity and converts the
enzyme from catalytically active dimers to inactive monomers, thereby
inhibiting LPL activity (10).
After disrupting the LPL dimer, ANGPTL4 is released. The LPL monomers remain
folded and stable but fail to re-form active dimers. These data suggest that
the N-terminal domain of ANGPTL4 interacts directly but transiently with LPL,
triggering a stable conformational switch in LPL that irreversibly inactivates
the enzyme.Recently, we used a population-based resequencing strategy to examine the
metabolic role of ANGPTL4 in humans
(11). Resequencing the coding
region of ANGPTL4 in a large (n = 3,501), multiethnic sample
revealed multiple rare sequence variations that alter an amino acid in the
protein and are associated with low plasma TG levels. In addition, we
identified a more common variant (E40K), that was present in ∼3% of
European-Americans and was associated with significantly lower plasma levels
of TG and low density lipoprotein-cholesterol (LDL-C), and higher levels of
high density lipoprotein (HDL)-C in two large epidemiological studies
(11). These association
studies confirmed that ANGPTL4 is involved in TG metabolism in humans, and
also revealed additional roles in humans in the metabolism of HDL and LDL,
which were not apparent from studies in genetically modified mice.Here we examined the synthesis, secretion, and processing of ANGPTL4 and
determine the mechanism by which substitution of a basic (lysine) for an
acidic (glutamate) residue at residue 40 affects the function of the
protein. 相似文献